In Vitro and In Vivo Performance of Novel Spray Dried Andrographolide Loaded Scleroglucan Based Formulation for Dry Powder Inhaler

Publisher： Bentham Science Publishers

E-ISSN： 1875-5704|14|7|968-980

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.14, Iss.7, 2017-10, pp. : 968-980

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Background: Current therapy for pulmonary arterial hypertension (PAH) is unable to preventprogression of disease due to continuous infusions and multiple oral administrations. This resultedin the need of novel treatment which would target directly structural vascular changes that weakenblood flow through pulmonary circulation.lt;/Pgt

Related content

Towards a More Desirable Dry Powder Inhaler Formulation: Large Spray-Dried Mannitol Microspheres Outperform Small Microspheres

By Kaialy Waseem   Hussain Tariq   Alhalaweh Amjad   Nokhodchi Ali  

Pharmaceutical Research, Vol. 31, Iss. 1, 2014-01 ,pp. : 60-76 (17)

Springer Publishing Company

Access to resources Recommend Favorite

The Effects of Loaded Carrier Mass and Formulation Mass on Aerosolization Efficiency in Dry Powder Inhaler Devices

By  

Current Drug Delivery, Vol. 12, Iss. 1, 2015-02 ,pp. : 40-46 (7)

Bentham Science Publishers

Access to resources Recommend Favorite

Prediction of Dry Powder Inhaler Formulation Performance From Surface Energetics and Blending Dynamics

By Saleem Imran   Smyth Hugh   Telko Martin  

Drug Development and Industrial Pharmacy, Vol. 34, Iss. 9, 2008-09 ,pp. : 1002-1010 (9)

Informa Healthcare

Access to resources Recommend Favorite

The Contribution of Different Formulation Components on the Aerosol Charge in Carrier-Based Dry Powder Inhaler Systems

By Hoe Susan   Traini Daniela   Chan Hak-Kim   Young Paul  

Pharmaceutical Research, Vol. 27, Iss. 7, 2010-07 ,pp. : 1325-1336 (12)

Springer Publishing Company

Access to resources Recommend Favorite

Development of Liposomal Amphotericin B Dry Powder Inhaler Formulation

By Shah S.   Misra Ambikanandan  

Drug Delivery, Vol. 11, Iss. 4, 2004-01 ,pp. : 247-253 (7)

Informa Healthcare

Access to resources Recommend Favorite